IBSA Derma

Founded by a group of Swiss biologists in 1945, IBSA – InstituteBiochemical SA – has gained unique experience in pharmaceutical research and technology. IBSA has used its experience and expertise in the pharmaceutical field to branch out and develop medical devices for dermatology based on hyaluronic acid, creating a dedicated dermoaesthetic brand IBSA Derma, which became rapidly one of the leading pharmaceutical companies for the production of hyaluronic acid in dermoaesthetic applications.

 

IBSA Derma distinguishes itself in this vast market because it controls the entire product life cycle: from the biofermentation production of the raw material to it being ready to use in pre-filled syringes. The company now offers a complete range of products, including Profhilo, a new innovative solution for skin rejuvenation,  whose production, from research to trading, is completely Italian.